PS1375 UPDATED SAFETY AND EFFICACY FROM A PHASE 2 STUDY OF VENETOCLAX PLUS CARFILZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA

Autor:	W. Munasinghe, N. Burwick, S. Gudipati, O. Bueno, F. Davies, A. Jakubowiak, E. Stadtmauer, T. Kovacsovics, L. Costa, G. Monohan, J. Pesko, S. Mudd, J. Ross, K. Freise, W.-J. Hong, S. Kumar, Jonathan L. Kaufman
Rok vydání:	2019
Předmět:	Oncology medicine.medical_specialty Venetoclax business.industry Phases of clinical research Hematology medicine.disease Carfilzomib chemistry.chemical_compound chemistry Internal medicine Relapsed refractory medicine In patient business Dexamethasone Multiple myeloma medicine.drug
Zdroj:	HemaSphere. 3:629
ISSN:	2572-9241
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::c9a56ed98a95bc8a4732322a953a74ab https://doi.org/10.1097/01.hs9.0000563776.65272.b6 Zobrazit plný text záznamu Plný text